MKI67 and cancer: Our data clearly showed that CX-5461 treatment of human cancer cell line CaSki (and in LN18 and A375) resulted in antiproliferative effects (Ki67 data) and DNA damage via the formation of double-stranded DNA breaks, as shown by the marker γH2AX.